An alarming number of people across Africa may be taking cancer drugs that don't contain the vital ingredients needed to contain or reduce their disease. It's a concerning finding with roots in a complex problem: how to regulate a range of therapeutics across the continent. A US and pan-African research group published the findings this week in The Lancet Global Health. The researchers had collected dosage information, sometimes covertly, from a dozen hospitals and 25 pharmacies across Ethiopia,...